Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
PFAS, synthetic chemicals found in many common products, may be contributing to an increase in liver problems, such as fatty liver disease.
Nearly 200 cases of pediatric hepatitis have now been reported in more than a dozen countries and several states.
However, older people were more likely to experience adverse events, especially if they used ribavirin.
Higher daily alcohol consumption was linked to greater risk for MAFLD.
The current leading suspect is an adenovirus, but much more remains to be learned.
CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.
NIAID is preparing for the possibility of future variants evading protection against currently available COVID-19 vaccines.
Universal HCV testing led to an increase in the number of pregnant women and infants diagnosed in a timely manner.
Antiviral therapy reduced the need for hospitalization and emergency treatment for liver-related and other conditions.
Immunocompromised people ages 12 and older are also eligible for an additional shot.
The higher risk for women with longer periods does not appear to be related to obesity.
Researchers showed that B cells evolve after COVID-19 vaccination to help improve protection against SARS-CoV-2 over time.
Pickings for concurrent treatment are slim in Ending the HIV Epidemic rural communities.
Boosters reduced the risk of hospitalization and death by about 80% for people with HIV, cancer, autoimmune conditions or organ transplants.
Screening for hepatitis B virus and liver cancer prevention were promoted through the KakaoTalk app.
Men and Black people were more likely to have antibodies against hepatitis C virus.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.